You don't like needles! no problem. There is a nasal spray available now.
Bharat Biotech's ChAd36-SARS-CoV-S Covid-19 (Chimpanzee Adenovirus Vectored) recombinant nasal vaccine was approved by the Drugs Controller General of India (DCGI). In 18+ age group. It is the primary immunization against Covid-19 (Wuhan virus).
The approval came after the Hyderabad-based Bharat Biotech completed clinical trials with four thousand volunteers. There were no side effects or adverse reactions to the medication according to the company sources.
Collaboration team:
Bharath Biotech
American Precision Virologics
Washington University School of Medicine, St Louis, Missouri
An earlier post on the nasal delivery:
https://hodentek.blogspot.com/2021/02/breaking-news-covaxin-getting-ready-for.html
More here:
https://en.wikipedia.org/wiki/Bharat_Biotech
https://www.bharatbiotech.com/intranasal-vaccine.html
Some pictures from the above site:
No comments:
Post a Comment